{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:56:40Z","timestamp":1787587000996,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejim.2023.03.006","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T12:14:00Z","timestamp":1679400840000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0224-7501","authenticated-orcid":false,"given":"Yoshito","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Colgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-7797","authenticated-orcid":false,"given":"Harrison","family":"Kistler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0091-0082","authenticated-orcid":false,"given":"Francisco","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejim.2023.03.006_bib0001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3949\/ccjm.83a.14061","article-title":"Alcohol withdrawal syndrome in medical patients","volume":"83","author":"Gortney","year":"2016","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"10.1016\/j.ejim.2023.03.006_bib0002","first-page":"e13282","article-title":"Phenobarbital versus lorazepam for management of alcohol withdrawal syndrome: a retrospective cohort study","volume":"13","author":"Hawa","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ejim.2023.03.006_bib0003","unstructured":"Agency for Healthcare Research and Quality. Statistical Brief #249. Healthcare Cost and Utilization Project (HCUP). 2019. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb249-Mental-Substance-Use-Disorder-Hospital-Stays-2016.jsp. Accessed October 29 2022."},{"issue":"4","key":"10.1016\/j.ejim.2023.03.006_bib0004","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40265-015-0358-1","article-title":"Identification and management of alcohol withdrawal syndrome","volume":"75","author":"Mirijello","year":"2015","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.ejim.2023.03.006_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0018578717720310","article-title":"Patient outcomes associated with phenobarbital use with or without benzodiazepines for alcohol withdrawal syndrome: a systematic review","volume":"52","author":"Hammond","year":"2017","journal-title":"Hosp Pharm"},{"issue":"1","key":"10.1016\/j.ejim.2023.03.006_bib0006","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00134-012-2758-y","article-title":"Alcohol withdrawal and delirium tremens in the critically ill: a systematic review and commentary","volume":"39","author":"Awissi","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejim.2023.03.006_bib0007","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcrc.2015.11.022","article-title":"Barbiturates for the treatment of alcohol withdrawal syndrome: A systematic review of clinical trials","volume":"32","author":"Mo","year":"2016","journal-title":"J Crit Care"},{"issue":"2","key":"10.1016\/j.ejim.2023.03.006_bib0008","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ajem.2019.01.053","article-title":"Single dose phenobarbital in addition to symptom-triggered lorazepam in alcohol withdrawal","volume":"38","author":"Ibarra","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.03.006_bib0009","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1360-0443.2005.00916.x","article-title":"Primary medical care and reductions in addiction severity: a prospective cohort study","volume":"100","author":"Saitz","year":"2005","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.ejim.2023.03.006_bib0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0304-3940(02)00399-3","article-title":"Ethanol withdrawal upregulates kainate receptors in cultured rat hippocampal neurons","volume":"327","author":"Carta","year":"2002","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.ejim.2023.03.006_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/alcalc\/agh117","article-title":"Upregulation of glutamate receptor subtypes during alcohol withdrawal in rats","volume":"40","author":"Haugb\u00f8l","year":"2005","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.ejim.2023.03.006_bib0012","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00007611-199101000-00006","article-title":"Pharmacokinetic dosing of phenobarbital in the treatment of alcohol withdrawal syndrome","volume":"84","author":"Ives","year":"1991","journal-title":"South Med J"},{"issue":"9","key":"10.1016\/j.ejim.2023.03.006_bib0013","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.0013-9580.2004.12704.x","article-title":"Phenobarbital for the treatment of epilepsy in the 21st century: a critical review","volume":"45","author":"Kwan","year":"2004","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.ejim.2023.03.006_bib0014","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40266-018-0562-2","article-title":"Pharmacokinetic factors to consider in the selection of antiseizure drugs for older patients with epilepsy","volume":"35","author":"Anderson","year":"2018","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.ejim.2023.03.006_bib0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0447.1978.tb06930.x","article-title":"Delirium tremens: a double-blind comparison of diazepam and barbital treatment","volume":"58","author":"Kramp","year":"1978","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.ejim.2023.03.006_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.08.013","article-title":"Identification and management of acute alcohol intoxication","volume":"108","author":"Mirijello","year":"2023","journal-title":"Eur J Int Med"},{"key":"10.1016\/j.ejim.2023.03.006_bib0017","unstructured":"Lewis CB, Adams N. Phenobarbital. 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532277\/. Accessed February 19 2023."},{"issue":"11","key":"10.1016\/j.ejim.2023.03.006_bib0018","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/0885066619847119","article-title":"Practice Patterns in the Treatment of Patients With Severe Alcohol Withdrawal: A Multidisciplinary, Cross-Sectional Survey","volume":"35","author":"Buell","year":"2020","journal-title":"J Intensive Care Med"},{"issue":"12","key":"10.1016\/j.ejim.2023.03.006_bib0019","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1177\/1060028021999821","article-title":"Adjunctive Phenobarbital for Alcohol Withdrawal Syndrome: A Focused Literature Review","volume":"55","author":"Murphy","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2023.03.006_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jclinepi.2020.03.016","article-title":"Reporting scoping reviews-PRISMA ScR extension","volume":"123","author":"McGowan","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.ejim.2023.03.006_bib0021","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2023.03.006_bib0022","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2016.02.016","article-title":"Phenobarbital compared to benzodiazepines in alcohol withdrawal treatment: a register-based cohort study of subsequent benzodiazepine use, alcohol recidivism and mortality","volume":"161","author":"Askgaard","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ejim.2023.03.006_bib0023","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202203-0466LE","article-title":"Phenobarbital for severe alcohol withdrawal syndrome: a multicenter retrospective cohort study","author":"Bosch","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.03.006_bib0024","first-page":"31","article-title":"Comparison of alcohol withdrawal outcomes in patients treated with benzodiazepines alone versus adjunctive phenobarbital: a retrospective cohort study","volume":"4","author":"Gashlin","year":"2015","journal-title":"Asia Pacific J Medical Toxicol"},{"issue":"5","key":"10.1016\/j.ejim.2023.03.006_bib0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0018578720931464","article-title":"Evaluation of a phenobarbital-based protocol for severe alcohol withdrawal in critically Ill patients","volume":"56","author":"Goodberlet","year":"2021","journal-title":"Hosp Pharm"},{"issue":"4","key":"10.1016\/j.ejim.2023.03.006_bib0026","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ajem.2009.10.010","article-title":"A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal","volume":"29","author":"Hendey","year":"2011","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.ejim.2023.03.006_bib0027","first-page":"A4169","article-title":"Phenobarbital versus diazepam for delirium tremens\u2013a retrospective study","volume":"57","author":"Hjerm\u00f8","year":"2010","journal-title":"Dan Med Bull"},{"issue":"1","key":"10.1016\/j.ejim.2023.03.006_bib0028","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s13181-021-00863-2","article-title":"Return encounters in emergency department patients treated with phenobarbital versus benzodiazepines for alcohol withdrawal","volume":"18","author":"Lebin","year":"2022","journal-title":"J Med Toxicol"},{"issue":"7","key":"10.1016\/j.ejim.2023.03.006_bib0029","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/15563650.2018.1542701","article-title":"Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome","volume":"57","author":"Lee","year":"2019","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"10.1016\/j.ejim.2023.03.006_bib0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.psym.2020.01.008","article-title":"Phenobarbital for acute alcohol withdrawal management in surgical trauma patients\u2014a retrospective comparison study","volume":"61","author":"Nejad","year":"2020","journal-title":"Psychosomatics"},{"issue":"11","key":"10.1016\/j.ejim.2023.03.006_bib0031","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ajem.2018.03.049","article-title":"Incorporating phenobarbital into your symptom-based benzodiazepine alcohol withdrawal protocol in the emergency department","volume":"36","author":"Nelson","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.ejim.2023.03.006_bib0032","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajem.2019.01.002","article-title":"Benzodiazepines vs barbiturates for alcohol withdrawal: Analysis of 3 different treatment protocols","volume":"37","author":"Nelson","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ejim.2023.03.006_bib0033","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.alcohol.2019.07.004","article-title":"Phenobarbital and symptom-triggered lorazepam versus lorazepam alone for severe alcohol withdrawal in the intensive care unit","volume":"82","author":"Nguyen","year":"2020","journal-title":"Alcohol"},{"issue":"5","key":"10.1016\/j.ejim.2023.03.006_bib0034","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.psym.2019.02.002","article-title":"Use of phenobarbital in alcohol withdrawal management \u2013 a retrospective comparison study of phenobarbital and benzodiazepines for acute alcohol withdrawal management in general medical patients","volume":"60","author":"Nisavic","year":"2019","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ejim.2023.03.006_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.alcohol.2022.05.001","article-title":"A retrospective evaluation of phenobarbital versus benzodiazepines for treatment of alcohol withdrawal in a regional Canadian emergency department","volume":"102","author":"Pistore","year":"2022","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.ejim.2023.03.006_bib0036","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jemermed.2012.07.056","article-title":"Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study","volume":"44","author":"Rosenson","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ejim.2023.03.006_bib0037","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ajem.2022.02.020","article-title":"Phenobarbital and\/or benzodiazepines for recurrent alcohol withdrawal: A self-controlled, retrospective cohort study","volume":"54","author":"Staidle","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"7","key":"10.1016\/j.ejim.2023.03.006_bib0038","first-page":"1313","article-title":"Comparison of phenobarbital-adjunct versus benzodiazepine-only approach for alcohol withdrawal syndrome in the ED","volume":"37","author":"Sullivan","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.ejim.2023.03.006_bib0039","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4037\/ajcc2018745","article-title":"Treatment of alcohol withdrawal syndrome: phenobarbital vs CIWA-Ar Protocol","volume":"27","author":"Tidwell","year":"2018","journal-title":"Am J Crit Care"},{"issue":"1","key":"10.1016\/j.ejim.2023.03.006_bib0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the american epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.ejim.2023.03.006_bib0041","article-title":"Correlation between and nursing satisfaction with CIWA-Ar, mMINDS, and SEWS scoring tools for the assessment of severe alcohol withdrawal syndrome in ICU Patients","author":"Bradley","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.ejim.2023.03.006_bib0042","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1553-2712.2010.00885.x","article-title":"Feasibility and Reliability of the SHOT: a short scale for measuring pretreatment severity of alcohol withdrawal in the emergency department","volume":"17","author":"Gray","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.03.006_bib0043","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0018578718769241","article-title":"The assessment and management practices of acute alcohol withdrawal: results of a nationwide survey of critical care pharmacists","volume":"54","author":"Dyal","year":"2019","journal-title":"Hosp Pharm"},{"issue":"5","key":"10.1016\/j.ejim.2023.03.006_bib0044","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/alcalc\/agv043","article-title":"Prospective validation study of the prediction of alcohol withdrawal severity scale (PAWSS) in medically ill inpatients: a new scale for the prediction of complicated alcohol withdrawal syndrome","volume":"50","author":"Maldonado","year":"2015","journal-title":"Alcohol Alcohol"},{"issue":"5","key":"10.1016\/j.ejim.2023.03.006_bib0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.mayocpiqo.2020.06.002","article-title":"Retrospective analysis of gabapentin for alcohol withdrawal in the hospital setting: the mayo clinic experience","volume":"4","author":"Bates","year":"2020","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"3","key":"10.1016\/j.ejim.2023.03.006_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.08.042","article-title":"Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam","volume":"119","author":"Addolorato","year":"2006","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.ejim.2023.03.006_bib0047","article-title":"Baclofen for alcohol withdrawal","volume":"8","author":"Liu","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejim.2023.03.006_bib0048","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","article-title":"Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial","volume":"180","author":"Anton","year":"2020","journal-title":"JAMA Internal Medicine"},{"issue":"9603","key":"10.1016\/j.ejim.2023.03.006_bib0049","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0140-6736(07)61789-9","article-title":"Baclofen for alcoholism","volume":"370","author":"Garbutt","year":"2007","journal-title":"Lancet"},{"issue":"02","key":"10.1016\/j.ejim.2023.03.006_bib0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/a-1798-2872","article-title":"Treating alcohol use disorder in patients with alcohol-associated liver disease: controversies in pharmacological therapy","volume":"42","author":"Tarli","year":"2022","journal-title":"Semin Liver Dis"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T11:42:09Z","timestamp":1737373329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":50,"alternative-id":["S0953620523000845"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.03.006","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}